(Financial Times) Vaccine makers Pfizer Inc. and Moderna Inc. have raised their Covid-19 vaccine prices days after signing new supply contracts in the European Union. Pfizer’s short will now sell…
(Reuters) Pfizer has raised its forecasts of sales of joint vaccines with BioNTech by 28.8% to $35.5 billion. The upgraded Covid-19 vaccine sales reflects signed deals of 2.1 billion doses…
Pfizer expects to sell about $15 billion in coronavirus vaccine doses in 2021, according to the company’s press release. The drugmaker forecasts its revenue to be in the range of…
Pfizer and BioNTech agreed on Wednesday with the U.S. government to supply additional 100 million doses of COVID-19 vaccine, according to the company’s press release. The agreement brings the total…
U.S. Pfizer and its German partner BioNTech have applied to the European Medicines Agency (EMA) for the authorization of the BNT162b2 vaccine candidate, according to press release. If approved, the…
Pfizer and BioNTech SE’s mRNA-based vaccine candidate BNT162b2 is 90% effective in preventing COVID-19 in participants without prior evidence of SARS-COV-2 infection, according to the company’s press release. The results…